Biostem Technologies, Inc. is an innovator, which is focused on harnessing the natural properties of perinatal tissue in the development, manufacturing and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products through its BioRetain processing method. BioRetain has been developed by applying the research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. The Company’s portfolio of brands includes VENDAJE, VENDAJE AC and VENDAJE OPTIC. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is a structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Annual Dividend Rate
Price/Cash Flow (TTM)